PLA2G5 Antikörper (C-Term)
Kurzübersicht für PLA2G5 Antikörper (C-Term) (ABIN4889021)
Target
Alle PLA2G5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with the 16 kDa human PLA2G5 protein
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide derived from C terminal part of human PLA2G5 protein.
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- PLA2G5 (phospholipase A2, Group V (PLA2G5))
-
Andere Bezeichnung
- Calcium-Dependent Phospholipase A2 (PLA2G5)
-
Hintergrund
- Belongs to the phospholipase A2 family. Defects in PLA2G5 are the cause of fleck retina, familial benign
-
UniProt
- P04054
-
Pathways
- Inositol Metabolic Process
Target
-